Cargando…
Induced Pluripotent Stem Cell Technology and Direct Conversion: New Possibilities to Study and Treat Parkinson’s Disease
Recent developments in in vitro disease modeling and regenerative medicine have placed induced pluripotent stem cells (iPSCs) in the center of attention as a unique source to study Parkinson’s disease. After only 5 years of intensive research, human iPSCs can be generated without viral integration a...
Autores principales: | Roessler, Reinhard, Boddeke, Erik, Copray, Sjef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742952/ https://www.ncbi.nlm.nih.gov/pubmed/22529017 http://dx.doi.org/10.1007/s12015-012-9369-4 |
Ejemplares similares
-
Dynamic Changes in Ezh2 Gene Occupancy Underlie Its Involvement in Neural Stem Cell Self-Renewal and Differentiation towards Oligodendrocytes
por: Sher, Falak, et al.
Publicado: (2012) -
Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson’s Disease
por: Peng, Su-Ping, et al.
Publicado: (2015) -
Detailed Analysis of the Genetic and Epigenetic Signatures of iPSC-Derived Mesodiencephalic Dopaminergic Neurons
por: Roessler, Reinhard, et al.
Publicado: (2014) -
Apocynin, a Low Molecular Oral Treatment for Neurodegenerative Disease
por: ‘t Hart, Bert A., et al.
Publicado: (2014) -
Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson’s disease
por: Melo, T. Q., et al.
Publicado: (2016)